Pyrexia, commonly known as fever, is a prevalent symptom in various clinical conditions, necessitating an in-depth understanding for effective management. This article aims to elucidate the complexities surrounding pyrexia and provide a comprehensive guide for its clinical management.
Pyrexia is primarily a response to pathogenic invasion or tissue damage, instigated by the release of pyrogens. These pyrogens act on the hypothalamus, altering the body's thermoregulatory set-point. Various factors, including infections, malignancies, autoimmune diseases, and certain medications, can trigger this response.
An accurate history and a thorough physical examination are crucial in the evaluation of pyrexia. Identifying the pattern of fever, associated symptoms, and potential exposure history can provide valuable clues to the underlying etiology. Diagnostic investigations should be guided by the clinical suspicion.
Management of pyrexia involves treating the underlying cause and symptomatic relief for the patient. Antipyretics are commonly used for symptomatic management, but their use should be balanced against the potential benefits of fever as a natural defense mechanism. In cases of persistent fever, despite treatment, a re-evaluation of the diagnosis should be considered.
In pediatric and geriatric populations, pyrexia may present atypically and can be associated with severe complications. Therefore, a high index of suspicion and a tailored approach are required in these populations. In critically ill patients, fever can contribute to increased metabolic demand and should be managed aggressively.
Understanding the etiology, clinical assessment, and management strategies of pyrexia is essential in clinical practice. While fever is a common symptom, its implications can be far-reaching, and a comprehensive approach is necessary for optimal patient care. This guide serves as a foundation for such an approach, promoting effective management of pyrexia in various clinical scenarios.
1.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
What Comes After Cancer?
4.
FDA Expands Durvalumab Label to Operable Lung Cancer
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Finding Support: Connecting with the Vitiligo Community
2.
Essential Updates in Hematology in Daily Practice
3.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
4.
Living Better With Advanced Cancer Through Supportive Care
5.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation